3,7-Dihydro-1,7-dimethyl-1H-purin-2,6-dion

Paraxanthine

HCID 4687CAS 611-59-6

Grundinformationen

Standard-SMILES
Cn1c(=O)[nH]c2ncn(C)c2c1=O
InChIKey
QUNWUDVFRNGTCO-UHFFFAOYSA-N
Summenformel
C7H8N4O2
Durchschnittliche Molmasse
180,16 g/mol
Monoisotopische Masse
180,06472551

Namen und Bezeichner

Bevorzugter Name
Paraxanthine
IUPAC
1,7-dimethyl-3H-purine-2,6-dione
Lokaler Name
3,7-Dihydro-1,7-dimethyl-1H-purin-2,6-dion
Englischer Name
1,7-Dimethylxanthine
Summenformel
C7H8N4O2
Molmasse
180.16

Namen und Synonyme

paraxanthine1,7-Dimethylxanthine611-59-6p-Xanthine1,7-dimethyl-3H-purine-2,6-dione1H-Purine-2,6-dione, 3,7-dihydro-1,7-dimethyl-DTXSID20522811,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dioneNSC-400018Q3565Y41V7DTXCID2030853
Weitere Namen anzeigen
Paraxanthin1,7-Dimethyl-1H-purine-2,6-dione, 1,7-Dimethylxanthine, 2,6-Dihydroxy-1,7-dimethylpurine, ParaxanthineParaxanthine-d3Paraxanthine solution
CHEBI:25858RefChem:417792210-271-91,7-Dimethyl-1H-purine-2,6(3H,7H)-dione3,7-Dihydro-1,7-dimethyl-1H-purine-2,6-dioneXanthine, 1,7-dimethyl-Caffeine Impurity FCaffeine EP Impurity F

Datenbank-Bezeichner

CAS
611-59-6
PubChem CID
4687
DTXSID
DTXSID2052281
ChEMBL
CHEMBL1158
ChEBI
CHEBI:25858
UNII
Q3565Y41V7
EC Number
210-271-9
Nikkaji
J2.991B

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,2
Polarare Oberfläche (TPSA)
67,2 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
0
Schwere Atome
13

Experimentelle und physikochemische Eigenschaften

Solubility>27 [ug/mL] (The mean of the results at pH 7.4)
Melting Point351 - 352 °C
Physical Description · 2 Einträge

Faint yellow fine crystals; [MSDSonline]

Solid

Collision Cross Section · 6 Einträge

134.2 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID2052281];136.8 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID2052281]

149.5 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];134 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];138.7 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

130.85 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];137.69 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];125.98 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];138.86 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

132.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

135.63 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]

133.24 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

Physikochemische Eigenschaften

Schmelzpunkt
294 · 294-296 °C (lit.)
Siedepunkt
312.97 °C · 312.97°C (rough estimate)
Dichte
1.364 · 1.3640 (rough estimate)
Brechungsindex
1.67 · 1.6700 (estimate)
Flammpunkt
9 ℃ · 9℃
storage temp.
room temp

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 6.7% (3 of 45) of reports.

Warning

H302 (93.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 3 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 3 of 45 reports by companies.;There are 2 notifications provided by 42 of 45 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazards SummaryA skin, eye, and respiratory tract irritant; [MSDSonline]
Hazard Classes and CategoriesAcute Tox. 4 (93.3%)

Toxikologische Informationen

USGS Health-Based Screening Levels for Evaluating Water-Quality · 3 Einträge

1,7-Dimethylxanthine

Pharmaceutical

Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP

Sicherheitsdaten

wgk
3
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
hs_code
2933.59.9500
RTECS-Nr.
RV9380000
risk_code
22-39/23/24/25-23/24/25-11
Toxizität
mmo-esc 150 mg/L CSHSAZ 16,337,52

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesParaxanthine has known human metabolites that include 1,7-Dimethyluric acid and 1-Methylxanthine.;Paraxanthine is a known human metabolite of caffeine.
Tissue LocationsKidney;Liver;Placenta;Prostate
Cellular LocationsCytoplasm
Metabolite PathwaysCaffeine Metabolism

Verwendung und Herstellung

Use ClassificationPharmaceuticals
Anwendungen · 2 Einträge

BeschreibungParaxanthine is an inhibitor of phosphodiesterase 9 (PDE9) and an antagonist of adenosine receptors A1 and A2 (Kis = 35 and 22 μM, respectively in equine forebrain tissues). It is the main metabolite of caffeine in humans, making up 80% of the three dimethylxanthine metabolites produced by caffeine demethylation. Paraxanthine increases locomotor activity and counteracts adenosine receptor agonist-induced motor depression in rats not habituated to caffeine. At a dose of 30 mg/kg, paraxanthine induces a significant increase in striatal cGMP and extracellular striatal dopamine concentrations in vivo. It also promotes wakefulness and increases locomotor activity and core temperature in narcoleptic transgenic mice without increasing behavioral anxiety.

Verwenden1,7-Dimethylxanthine has been used for the quantification of caffeine by high-performance liquid chromatography (HPLC).

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

Anbieter50 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]
成都普瑞法科技开发有限公司+86-028-82633397 18982077548 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
山东科立康药业有限公司053-88113608 17854192669
艾吉析科技(上海)有限公司17717235263 · [email protected]

Zugehörige Reaktionen

5

Verknüpfte Notizen

Wird geladen…